Cargando…

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974845/ https://www.ncbi.nlm.nih.gov/pubmed/27583275 http://dx.doi.org/10.1212/NXI.0000000000000273

Ejemplares similares

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months
por: De Mercanti, Stefania, et al.
Publicado: (2016)

Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment
por: Haas, Jürgen, et al.
Publicado: (2019)

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up
por: Rolla, Simona, et al.
Publicado: (2022)

Long-term efficacy of alemtuzumab in polymyositis
por: Ruck, Tobias, et al.
Publicado: (2015)

Alemtuzumab in the up-front setting
por: Kaufman, Matthew, et al.
Publicado: (2008)

Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223
por: Steingo, Brian, et al.
Publicado: (2020)

Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features
por: Pariani, Nadia, et al.
Publicado: (2018)

Correction: Helios expression and Foxp3 TSDR methylation of IFNy+ and IFNy- Treg from kidney transplant recipients with good long-term graft function
por: Trojan, Karina, et al.
Publicado: (2017)

Alemtuzumab
por: Tridente, Giuseppe
Publicado: (2013)

Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients
por: Kaplan, Adam, et al.
Publicado: (2020)

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings
por: Barclay, Krista, et al.
Publicado: (2019)

Personality Profiles Associated with Long-Term Success in Bariatric Surgery: 24-Month Follow-Up
por: Montorio, Ignacio, et al.
Publicado: (2023)

Correction: Inflammatory Stress on Autophagy in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease during 24 Months of Follow-Up
por: François, Arnaud, et al.
Publicado: (2016)

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Alemtuzumab in Covid era
por: Iovino, Aniello, et al.
Publicado: (2021)

Correction: Statin Use and Cognitive Function: Population-Based Observational Study with Long-Term Follow-Up
Publicado: (2015)

Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2010)

B Cell Repopulation After Alemtuzumab Induction—Transient Increase in Transitional B Cells and Long-Term Dominance of Naïve B Cells
por: Heidt, S, et al.
Publicado: (2012)

Correction: 24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy
por: Mazzone, Elena Stacy, et al.
Publicado: (2013)

Correction: The Effect of Cooled Perches on Immunological Parameters of Caged White Leghorn Hens during the Hot Summer Months
por: Strong, Rebecca A., et al.
Publicado: (2016)

Correction: Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study
por: Simons, Claudia J. P., et al.
Publicado: (2018)

Correction: Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
por: Schilte, Clémentine, et al.
Publicado: (2013)

Alemtuzumab in refractory Sézary syndrome
por: Reifs, Carmen María Alcántara, et al.
Publicado: (2016)

Alemtuzumab in chronic lymphocytic leukemia
por: Fraser, G., et al.
Publicado: (2007)

Alemtuzumab in the treatment of multiple sclerosis
por: Fernandez, Óscar
Publicado: (2014)

Alemtuzumab for the treatment of multiple sclerosis
por: Willis, Mark D, et al.
Publicado: (2015)

Correction: Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
por: Theil, Gerit, et al.
Publicado: (2022)

Correction: CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34a
Publicado: (2015)

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
por: Pane, Marika, et al.
Publicado: (2015)

Correction: Long Term Natural History Data in Ambulant Boys with Duchenne Muscular Dystrophy: 36-Month Changes
Publicado: (2015)

P805: ALEMTUZUMAB IN RELAPSED SEVERE APLASTIC ANEMIA: LONG-TERM RESULTS OF A PHASE II STUDY
por: Aggarwal, N., et al.
Publicado: (2022)

Long-Term Functional Results of Intra- and Extra-Articular Hand Fractures Treatment With Titanium Miniature Plates and Screws With Minimum Follow-Up of 24 Months
por: Varitimidis, Sokratis, et al.
Publicado: (2021)

Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies
por: Hunter, Samuel F., et al.
Publicado: (2021)

Author Correction: In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice
por: Li, Yongqin, et al.
Publicado: (2021)

Correction: The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance
por: Agtini, Magdarina D, et al.
Publicado: (2007)

Correction: Predicting the Long-Term Impact of Antiretroviral Therapy Scale-Up on Population Incidence of Tuberculosis
por: Dodd, Peter J., et al.
Publicado: (2013)

Correction to: Pediatric elbow arthroscopy: clinical outcomes and complications after long-term follow-up
por: Micheloni, Gian Mario, et al.
Publicado: (2022)

Correction: Subacute Subclinical Brain Infarctions after Transcatheter Aortic Valve Implantation Negatively Impact Cognitive Function in Long-Term Follow-Up
Publicado: (2017)

Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
por: Coles, Alasdair J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kngp6rh9c94g7jukba3sgbl227